Progenitor Cell Therapy Expands Contract Process Development Capacity

HACKENSACK, N.J.--(BUSINESS WIRE)--Progenitor Cell Therapy LLC (PCT) announced today a significant expansion of its process development contract service capabilities with the completion of new laboratory space and the addition of key staff at its Mountain View, California facility.

MORE ON THIS TOPIC